Human and AI Performance for Shared Decision-Making in Chronic Illness Management
By Dacre Knight, MD, MS, FACP | Medical Director, Ehlers-Danlos Clinic, Mayo Clinic
Advances and Challenges in Collaborative Healthcare
In an era dominated by technological advancements and AI integration, the dynamics of shared decision-making in managing chronic illnesses are evolving dramatically. While humans have relied on their intuition since the time of Hippocrates, the rise of AI offers new potential in enhancing the collaborative processes in healthcare.
A Historical Perspective
Shared decision making has long been a cornerstone of effective patient care and chronic disease management. From early medical councils to modern multidisciplinary teams, human deliberation has been pivotal in resolving conflicts and forging consensus on patient care plans. Historically, healthcare providers have relied on dialogue and negotiation to navigate complex treatment decisions, fostering a culture of inclusivity and collaboration.
The traditional approach faced several challenges, including cognitive biases, limited information processing capacity, and varying levels of expertise among participants. These limitations often hinder optimal patient outcomes and slow progress in chronic disease management.
In conclusion, the synergy between human expertise and AI presents an exciting frontier in managing chronic illnesses.
The Rise of AI in Healthcare
With the advent of AI and machine learning, a new paradigm in shared decision making for chronic illness management has emerged. AI systems can analyze vast amounts of medical data, identify patterns, and suggest evidence-based treatment options. This revolution is transforming the way decisions are made in healthcare, particularly in the management of chronic conditions.
Data-Driven Insights
AI leverages data analytics to uncover hidden insights that might elude human healthcare providers. These systems can process complex medical datasets and provide recommendations that are grounded in empirical evidence. This data-driven approach enhances the accuracy and efficiency of treatment decisions for chronic illnesses.
Bias Reduction
Human decision-making is often influenced by cognitive biases, which can lead to suboptimal outcomes. AI has the potential to mitigate these biases by offering objective assessments and recommendations. However, it is crucial to ensure that AI systems are trained to avoid replicating existing biases found in historical medical records.
Challenges and Ethical Considerations
While AI offers significant advantages, it also presents several challenges and ethical dilemmas. Ensuring data privacy, maintaining transparency in AI algorithms, and addressing issues of accountability are paramount. Additionally, there is a need to balance AI’s recommendations with human intuition and experience in patient care.
Case Studies
The Mayo Clinic Ehlers-Danlos syndromes (EDS) Clinic exemplifies the successful integration of AI in shared decision-making for chronic illness management.
Hypermobility Disorder Management
AI systems assist in monitoring patient response to therapy, predicting complications, and recommending personalized treatment plans for EDS patients. These systems support healthcare providers in making informed treatment decisions for chronically ill patients with EDS or mast cell activation syndrome (MCAS), ultimately improving patient outcomes. One study (Figure 1) identified the comparison of themes in clinical visits between human interpretation and AI tools like Nvivo-14 and Chat GPT. In this study, human interpretation was very similar to Chat GPT.
Cardiovascular Disease and POTS
In cardiovascular care, AI analyzes patient data to assess risks, suggest interventions, and monitor progress. Mayo Clinic leverages these insights to make strategic decisions that enhance patient care and mitigate risks associated with chronic autonomic conditions like POTS.
The Future
The integration of AI in shared decision-making offers a promising future for chronic illness management for patients with EDS, POTS, MCAS and other complex conditions. As AI continues to evolve, it will complement human capabilities, enhancing the accuracy and efficiency of collaborative healthcare processes. However, it is essential to navigate the ethical and practical challenges to ensure that AI serves as an ally in fostering inclusive and effective patient care.
In conclusion, the synergy between human expertise and AI presents an exciting frontier in managing chronic illnesses. By leveraging AI’s strengths while honoring human intuition, we can create robust frameworks for collaboration that drive innovation and improve patient outcomes. As we embrace this future, it is crucial to remain vigilant in addressing the ethical dimensions and ensuring that AI contributes positively to our healthcare endeavors.
Resources:
- Knight DRT. Cardiac defects of hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders: a retrospective cohort study. Front Cardiovasc Med. 2024; 11:1332508 Epub 2024 Mar 18
- Knight DR, Perlman AI, Halamka JD, Abu AM. Artificial intelligence for patient scheduling in the real-world health care setting: A metanarrative review Health Policy and Technology. 2023; 12(4).
- Darakjian AA, Knight DRT, Bruno KA. Similarities and differences in self-reported symptoms and comorbidities between hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders. Rheumatol Adv Pract. 2024; 8 (4):rkae134 Epub 2024 Nov 04
- Venable E, Knight DRT, Thoreson EK, Baudhuin LM. COL1A1 and COL1A2 variants in Ehlers-Danlos syndrome phenotypes and COL1-related overlap disorder. Am J Med Genet C Semin Med Genet. 2023 Jun; 193(2):147-159. Epub 2023 Mar 09.